Barry Meier, Drug Industry Plans Release of More Data About Studies, New York Times, January 7, 2005 (free registration required). Excerpt: 'Faced with pressure from lawmakers and editors of medical journals, four trade groups representing the world's biggest drug makers said yesterday that their members planned to release more data about clinical drug trials. In a joint statement, the groups said their member companies had committed themselves to disclose more information about drug studies, both when the studies are started and when results are released. The groups included the Pharmaceutical Research and Manufacturers Association in Washington and organizations in Europe and Japan....The industry is confronting two immediate problems. Drug makers are facing the prospect of federal legislation that would require them to register studies in a public database and post their results in it as a condition for running a trial. Separately, several prestigious medical journals have said they will soon stop publishing the results of clinical drug trials unless certain data about those studies are disclosed in a public database when a trial starts.'
Posted by
Peter Suber at 1/08/2005 02:26:00 PM.
The open access movement:
Putting peer-reviewed scientific and scholarly literature
on the internet. Making it available free of charge and
free of most copyright and licensing restrictions.
Removing the barriers to serious research.
